Xuan Guangshan

Qingdao University of Science and Technology professor. In 1987 he graduated from Nankai University Department of Chemistry, analytical chemistry, in 2001 graduated from the Department of Chemistry, Korea Kyungpook National University, analytical chemistry, obtained the doctorate of science. March 2001 to February 2002 in South Korea Ajou University postdoctoral study functional molecular disciplines. Has engaged in teaching and research work at Yanbian University, Konkuk University Korea etc. February 2004 so far in Chemical Engineering, Qingdao University of Science and taught. Speaker pharmaceutical analysis, medical polymer materials and other courses in recent years, chaired or participated in the national, provincial and ministerial projects 5 and a number of horizontal issues, has published more than 40 papers, which were SCI, EI included 19 papers. Currently, research studies drug intermediates synthesis and modification aspects; the development of colloidal gold, fluorescent immunoassay diagnostic reagents; pharmaceutical analysis research new techniques and methods; applied research and other biological materials in the field of medicine.

Professor Pan Profile

Pan Zhiqiang, male, physician, professor, Ph.D., director of medicine, doctoral tutor, Beijing Tongren Hospital Ophthalmology corneal specialist - eye bank director. Born in January 1965, the Chinese Academy of Ophthalmology Ophthalmology Branch members, corneal disease study group members, Beijing Ophthalmology Branch, vice chairman (chief secretary), any part-time "Chinese Journal of Ophthalmology" editorial board and the "International Review of Ophthalmology" editorial board.
Good, diagnosis and treatment of corneal disease, eye bank saving technology; infectious corneal disease, autoimmune diseases of cornea and conjunctiva and corneal graft rejection prevention response and the like. Long been engaged in diagnosis and treatment of ocular surface diseases, infectious corneal disease, autoimmune diseases of cornea and conjunctiva and corneal graft rejection prevention response has unique insights, in particular the results of basic research and clinical application of corneal stem cells related to ocular surface disease the treatment has opened up a new direction, she specializes in surgical treatment of anterior segment disease.
achievements: Over the past five years and complete commitment to the National Natural Science Foundation 2, involved in 15 research projects 1, 863 sub-project 1, 2005 selected The Ministry of Education & ldquo; new century excellent talents & rdquo ;. Participate in international academic conferences and speaking 5, 51 research papers, which SCI 7, the Beijing Municipal Science and Technology achievement prize two, a national invention patent applications.